The RAS gene family is one of the most frequently activated oncogenes in human cancer (Bos, 1989). RAS Summary proteins are small monomeric GTPases of 21 kDa that play a key role in transducing growth signals from cellActivating mutations of RAS frequently occur in subsurface receptors to the nucleus. Activating point musets of human cancers, indicating that RAS activation tations in RAS, which are found in tumors originating is important for tumorigenesis. However, a large profrom colon, lung, pancreas, and other tissues, promote portion of these cancers still retain wild-type RAS cellular transformation by growth-factor-independent alleles, suggesting that either the RAS pathway is acstimulation of cell proliferation and cell survival. In hutivated in a distinct manner or another pathway is demans, at least four RAS genes have been identified, regulated. To uncover novel tumor-suppressor genes, 
(ALG-2), and the homeodomain pituitary transcription To study the possible involvement of PITX1 in controlling oncogenic pathways, we first assessed the abilfactor PITX1, with a transforming activity comparable to RAS V12 overexpression ( Figure 1D ). Interestingly, ity of the PITX1 kd construct to suppress PITX1 gene expression. In transient transfections, PITX1 kd showed KLF4 was shown to exhibit putative tumor-suppressive functions in humans (Dang et Figure 2B ). Subsequently, notype was observed when PITX1 expression was suppressed ( Figures 3C and 3D) . Furthermore, only when we assayed extracts for phosphorylated ERK, which is a downstream target of RAS (Robinson and Cobb, the p53-p16 INK4A protective mechanisms were eliminated by suppressing their expression were cellular 1997). Clearly, higher levels of phospho-ERK were ob- tion in PITX1 levels also induces transformation in a primary human prostate model system, we obtained the primary-derived human prostate RWPE-1 cells (contain-
PITX1 Expression Patterns in Human Cancer
ing HPV and readily transformed by oncogenic K-RAS, To obtain support for PITX1 involvement in human can-ATCC). In soft agar assays, we found that the transduccer, we scanned the gene-expression database Ontion of RWPE-1 cells with the PITX1 kd , but not with a comine for differential PITX1 expression patterns in control vector, induces very efficient anchorage-indenormal versus tumor tissue of different sources. We pendent growth ( Figure 4A ). This result provides evifound PITX1 expression to be altered in prostate and dence that PITX1 is likely a relevant tumor suppressor bladder cancers relative to their normal tissue (Table  1) . In both cases, PITX1 expression was significantly for prostate cancer. 
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Several gene-expression studies comparing normal and cancer tissues were scanned for PITX1 using Oncomine software ( 
A Causal Relationship between PITX1 Levels
PITX1 expression in the colon cancer cells. First, using semiquantitative RT-PCR, we found that several colon and Wild-Type RAS in Colon Cancer Although activating RAS mutations are frequently found cancer cell lines express very low levels of PITX1 mRNA ( Figure 4C ). Significantly, the low levels of PITX1 in subsets of human cancers, other tumors in these panels contain no RAS mutations. For example, only expression correlated with the presence of wild-type RAS alleles (marked green). This correlation was veri-50% of all colon tumors, 30% of lung cancer, and 5% of prostate cancer in the United States are estimated fied by immunoblot analysis with PITX1 antiserum (Figure 4D) . These results can be explained by either the to contain oncogenic RAS mutation (Bos, 1989; Rhim, 2001). We therefore initially asked whether cancer cell fact that loss of PITX1 precludes the requirement to mutate RAS or the fact that PITX1 expression is relines with wild-type RAS genotypes exhibit enhanced RAS activity. We used pull-down experiments with GSTpressed by oncogenic RAS. Figure 4E and Figure S2 ), our data demonstrate a lines ( Figure 4B , cell lines with wt RAS alleles are marked with green ). Regardless of the RAS status, high causal relationship between reduced PITX1 levels and wild-type RAS. levels of RAS activity were observed in all the cancer cell lines tested. In contrast, no correlation was seen between the protein levels of RAS and its activity in the PITX1 Inhibits Growth and Tumorigenicity in a Wild-Type-RAS-Dependent Manner different cell extracts we used.
To investigate whether PITX1 contributes to the enThe correlation between wild-type RAS expression and low PITX1 levels in colon cancer cell lines suggests that hanced activity of endogenous wt RAS, we examined 
PITX1 restrains endogenous wt RAS activity. To test
In contrast, we found lower levels of phospho-ERK in PITX1-GFP-transfected cells compared with control, whether such a functional interaction exists, we constructed a retroviral vector containing PITX1-GFP and whereas the ERK2 levels remain unchanged ( Figure 5C,  lanes 1 and 3) . Interestingly, this effect was negated by checked its activity. Similar to endogenous PITX1, PITX1-GFP was localized in the nucleus and activated the cotransfection of RAS V12 (lanes 2 and 4). Together with the results presented in Figure 2 , these data indithe well-known PITX1 target the pro-opiomelanocortin To directly address the tumor-suppressive function shows that fragments of the RASAL1 promoter were efficiently precipitated from cells transfected with PITX1-of PITX1, we injected Caco-2 cells into the flank of athymic nude mice. These cells contained a 20%-25% GFP and immunoprecipitated with anti-GFP antibodies but not from control-transfected cells or immunopresubpopulation of cells with either PITX1-GFP or H2B-GFP control, with or without RAS V12 . After 3 weeks, tucipitation with a control antibody. Altogether, these results strongly suggest that RASAL1 is a transcription mors appeared in all mice and were isolated and analyzed by fluorescence microscopy and flow cytometry. target of PITX1. Finally, we tested the genetic interaction between We found very few PITX1-GFP-containing tumor cells, whereas the expected levels of GFP-positive cells were PITX1, RASAL1, and the RAS pathway. As observed above, overexpression of PITX1-GFP inhibited phosobserved in the tumors emerging from either PITX-GFP with RAS V12 or the H2B control cells ( Figure 5F ). We phorylation of ERK in a wild-type-RAS-dependent manner ( Figure 6F ). Introduction of RASAL1 kd (which results therefore conclude that in colon cancer cell lines that have low PITX1 expression and wt RAS genes, PITX1 in a more than 70% reduction in RASAL1 mRNA levels, Figure 6C ) or the controls PITX1 kd and overexpression re-expression suppresses growth and tumorigenicity in a wt-RAS-dependent manner.
of RAS V12 negated this effect, indicating that RASAL1 is a mediator of PITX1 effects. Control immunostainings showed similar levels of ERK2 and PITX1-GFP in those RASAL1 Mediates PITX1 Effects on RAS cells. Last, to examine whether RASAL1, similarly to Activity and Tumorigenicity PITX1, is part of a network that inhibits oncogenic Next we addressed the mechanism through which growth, we transduced Tr (-onc) cells with RASAL1 kd and PITX1 regulates RAS activity. Thus far, our results indiselected and plated them in soft agar to test for ancate a cell-autonomous mechanism for regulation of chorage-independent growth. Figure 6G shows that the RAS by PITX1 (Figures 5D-5F ), suggesting a direct coninhibition of RASAL1 expression induced tumorigenic nection between PITX1 and RAS rather than via growth growth that resembled the activity of PITX1 kd , indicatfactors. RAS is activated by GTP-exchange factors ing that RASAL1 is a mediator of RAS inhibition and (GEFs) and inhibited by GTP-activating factors (GAPs) tumor suppression by PITX1. However, as the activity (Repasky et al., 2004) . As a transcriptional activator, of RASAL1 kd was lower than that of PITX1 kd (approxi-PITX1 might activate a RAS-GAP to inhibit RAS activity mately half), whereas its effect on RASAL1 mRNA was ( Figure 6A ). To date, at least eight human RAS-GAP greater, it is likely that RASAL1 is not the only factor gene members are known: RASA1-4, RASAL1 and 2, mediating the PITX1 tumor-suppressive effects.
NF1, and SYN-GAP. We therefore searched for PITX1 consensus binding sites (TAA[T/G]CC) in 2 kb upstream promoter regions of these RAS-GAP genes and found
Conclusions Collectively, we describe here an approach to uncover only RASAL1 to contain this site ( Figure 6B ). RASAL1 is a RAS-GAP that senses and connects Ca 2+ signals tumor-suppressor genes that function as inhibitors of the RAS pathway. For this purpose, we used genetically to RAS activity through synchronous oscillatory association with the plasma membrane (Walker et al., 2004) . modified primary human fibroblasts whose sole requirement for transformation is the deregulation of RAS acTo test whether RASAL1 is a target of PITX1, we examined RASAL1 mRNA levels using quantitative Q-PCR.
tivity. This strategy is potentially also suitable for the identification of tumor suppressors that regulate other Transient transfection of HEK293 cells with PITX1-GFP more than doubled the endogenous RASAL1 levels proteins and pathways, such as p53 and p16 INK4A , whose inhibition was defined as a requirement for this over those of the H2B-GFP control ( Figure 6C) . Moreover, transfection of a RASAL1 kd construct reduced process (Hahn et al., 1999; Voorhoeve and Agami, 2003) . We demonstrate the power of this approach by RASAL1 mRNA levels by more than 70%, whereas suppression of PITX1 resulted in a reduction of 40%-50%. the identification of PITX1. PITX1 regulates the RAS pathway and thereby tumorigenesis. The tumor-supThe later result is expected, as RASAL1 kd causes an instant degradation of RASAL1 mRNA, whereas PITX1 kd is pressive function of PITX1 is supported by the correlation between the low PITX1 levels present in colon canexpected to reduce transcription activity of RASAL1 only after a significant reduction in PITX1 protein is cer cell lines and wt RAS expression (Figures 4 and 5) and the low PITX1 expression levels in prostate and achieved. To further examine the PITX1-RASAL1 connection in more detail, we cloned a 1.4 kb region includbladder tumor tissues compared with normal tissues (Table 1) . Moreover, we found in a primary-derived huing the PITX1 binding site and the predicted transcrip- kd -medineurofibromatosis type I, which is characterized by café-au-lait spots and fibromatous tumors of the skin ated transformation, which provides evidence that our transformation screen, although performed in fibro- (Buchberg et al., 1990) . It is interesting to note that while the inhibition of RASAL1 activity caused a transblasts, can identify relevant tumor suppressors for human cancer.
forming phenotype in our system ( Figure 6G ), knockdowns of NF1 showed no activity and NF1 expression We provide further genetic evidence for the regulation of the RAS pathway by PITX1 through RASAL1, a was not altered when PITX1 expression was suppressed (data not shown). Since the tumor-suppressive member of the RAS-GAP family. Interestingly, inhibition of RASAL1 expression potently induced tumorigenicity function of NF1 is restricted to certain nerve tissues, whereas that of PITX1 is found in prostate, bladder, and of human primary cells, suggesting that RASAL1, on its own, may also possess tumor-suppressive functions.
colon tissues, it is tempting to speculate that specific RAS-GAPs control RAS activity in different tissues, but Another tumor suppressor with a RAS-GAP activity is the neurofibromin (NF1) gene. Mutations in NF1 cause their inhibition is a general mechanism to provoke wt- tervention.
Soft Agar Assay Experimental Procedures
Cells were kd cells was ase system, Promega). The relative luciferase activity was calcudescribed before by Voorhoeve et al. (Voorhoeve and Agami, 2003) . lated as the activity of the reporter constructs compared to the BJ cells were infected with amphotropic retrovirus carrying an exrenilla activity. pression cassette for the ecotropic receptor (Brummelkamp et al., 2002a) and selected with 500 g/ml G418. After selection, the cells Chromatin Immunoprecipitation Assay were transduced with ecotropic retroviral supernatants in the pres-HEK293 cells were transfected with either PITX1-GFP or H2B-GFP. ence of 8 g/ml polybrene and selected with either 400 g/ml hyAfter 48 hr, the cells were harvested and crosslinked with 1% formgromycin B, 5 g/ml blasticidin or 1 g/ml puromycin. Caco-2 and aldehyde at room temperature for 20 min. The ChIP assay was per-RWPE-1 cells expressing an ecotropic receptor were generated by formed as previously described, using 25 g genomic DNA for each an amphotropic-retrovirus transduction.
analysis. ( 
